Viewing Study NCT00452855



Ignite Creation Date: 2024-05-05 @ 5:26 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00452855
Status: COMPLETED
Last Update Posted: 2007-03-29
First Post: 2007-03-26

Brief Title: Sevoflurane-Remifentanil Anaesthesia The Risk of Post Operative Nausea
Sponsor: Central Jutland Regional Hospital
Organization: Central Jutland Regional Hospital

Study Overview

Official Title: Postoperative Nausea and Vomiting Are Similar When Propofol or Sevoflurane Are Used as Adjuvant to Remifentanil During Anaesthesia for Gynaecological Surgery
Status: COMPLETED
Status Verified Date: 2007-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determine whether sevoflurane-remifentanil anaesthesia is similar to propofol-remifentanil anaesthesia concerning post- operative nausea and vomiting
Detailed Description: Propofol and sevoflurane anaesthesia are used world wide at the anaesthetists discretion

Propofol is superior to inhalational anaesthetics as anaesthesia for patients at risk of post operative nausea and vomiting PONV as PONV is diminished However when remifentanil is used as adjuvant to sevoflurane the total dose of the latter is reduced

Therefore we wanted to investigate if sevoflurane-remifentanil anaesthesia is similar to propofol-remifentanil anaesthesia with emphasis on nausea vomiting and total PONV during 24 hours

In the post anaesthesia care unit PACU and in the surgical ward nausea was scored on a visual analogue score Vomiting was registered

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None